• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未能从产前母血清游离细胞 DNA 检测中获得结果的影响:一项历史队列研究。

Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study.

机构信息

Sydney Medical School, University of Sydney, Sydney, NSW, Australia.

Sydney Ultrasound for Women, Sydney, NSW, Australia.

出版信息

BJOG. 2018 Jun;125(7):848-855. doi: 10.1111/1471-0528.15006. Epub 2017 Dec 6.

DOI:10.1111/1471-0528.15006
PMID:29090507
Abstract

OBJECTIVE

To investigate the pregnancy outcomes in a cohort of women who failed to obtain a result in non-invasive prenatal testing (NIPT).

DESIGN

Historical cohort study.

SETTING

A multicentre private practice in Sydney, Australia.

POPULATION

Women who failed to obtain a result from NIPT (n = 131).

METHODS

The maternal characteristics, antenatal investigations and pregnancy outcomes for these women were compared with those who obtained a result at the same practice and to the general Australian obstetric population.

MAIN OUTCOME MEASURES

Antenatal investigations: pregnancy-associated plasma protein-A (PAPP-A), free β-human chorionic gonadotrophin (β-hCG), placental growth factor (PlGF), uterine artery pulsatility index (PI), mean arterial pressure (MAP). Pregnancy outcomes: chromosomal abnormality, pre-eclampsia, gestational diabetes, small-for-gestational-age (SGA), preterm delivery.

RESULTS

Only 1.1% of NIPT samples failed to return a result. This cohort was significantly older and had significantly increased weight compared with the general Australian obstetric population. Pregnancy outcomes were available for 94% of the cohort. There were significantly higher rates of chromosomal aneuploidies (6.5% versus 0.2%, P < 0.0001), pre-eclampsia (11% versus 1.5%, P < 0.0001) and gestational diabetes (23% versus 7.5%, P < 0.0001) compared with the general obstetric population. Rates of preterm delivery and SGA were elevated but did not reach significance. Antenatal investigations demonstrated decreased PAPP-A MoM (0.75 versus 1.14, P < 0.0001), decreased free β-hCG (0.71 versus 1.01, P < 0.0001) and increased uterine artery PI (1.79 versus 1.65, P = 0.02).

CONCLUSION

Women who fail to obtain a result from NIPT are at increased risk of adverse pregnancy outcomes, in particular chromosomal aneuploidy, gestational diabetes and pre-eclampsia.

FUNDING

None received.

TWEETABLE ABSTRACT

Women who fail to obtain a result from cell-free DNA NIPT are at increased risk of adverse pregnancy outcomes.

摘要

目的

调查未能从无创产前检测(NIPT)中获得结果的女性队列的妊娠结局。

设计

历史队列研究。

地点

澳大利亚悉尼的多中心私人诊所。

人群

未能从 NIPT 获得结果的女性(n=131)。

方法

将这些女性的母体特征、产前检查和妊娠结局与同一诊所获得结果的女性以及澳大利亚一般产科人群进行比较。

主要观察指标

产前检查:妊娠相关血浆蛋白-A(PAPP-A)、游离β-人绒毛膜促性腺激素(β-hCG)、胎盘生长因子(PlGF)、子宫动脉搏动指数(PI)、平均动脉压(MAP)。妊娠结局:染色体异常、子痫前期、妊娠期糖尿病、胎儿生长受限(SGA)、早产。

结果

只有 1.1%的 NIPT 样本未能返回结果。与澳大利亚一般产科人群相比,该队列年龄明显较大,体重明显增加。94%的队列获得了妊娠结局。染色体非整倍体的发生率明显较高(6.5%对 0.2%,P<0.0001),子痫前期(11%对 1.5%,P<0.0001)和妊娠期糖尿病(23%对 7.5%,P<0.0001)的发生率也明显较高。早产和 SGA 的发生率升高,但未达到显著水平。产前检查显示 PAPP-A MoM 降低(0.75 对 1.14,P<0.0001),游离β-hCG 降低(0.71 对 1.01,P<0.0001),子宫动脉 PI 升高(1.79 对 1.65,P=0.02)。

结论

未能从游离细胞 DNA NIPT 中获得结果的女性发生不良妊娠结局的风险增加,特别是染色体非整倍体、妊娠期糖尿病和子痫前期。

研究资助

无。

研究结果在推特上的推广语

未能从游离 DNA NIPT 中获得结果的女性发生不良妊娠结局的风险增加。

相似文献

1
Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study.未能从产前母血清游离细胞 DNA 检测中获得结果的影响:一项历史队列研究。
BJOG. 2018 Jun;125(7):848-855. doi: 10.1111/1471-0528.15006. Epub 2017 Dec 6.
2
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.11-13 孕周筛查子痫前期:使用妊娠相关血浆蛋白-A、胎盘生长因子或两者联合。
Ultrasound Obstet Gynecol. 2020 Sep;56(3):400-407. doi: 10.1002/uog.22093. Epub 2020 Aug 5.
3
A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers.一种利用非整倍体和子痫前期筛查标志物的妊娠早期妊娠糖尿病预测模型。
J Matern Fetal Neonatal Med. 2018 Aug;31(16):2122-2130. doi: 10.1080/14767058.2017.1336759. Epub 2017 Jun 18.
4
Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free beta-hCG and with second-trimester uterine artery Doppler.孕早期母体血清妊娠相关血浆蛋白A和游离β-人绒毛膜促性腺激素以及孕中期子宫动脉多普勒超声对妊娠并发症的预测
Prenat Diagn. 2005 Oct;25(10):949-53. doi: 10.1002/pd.1251.
5
Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.前瞻性评估早孕期子痫前期筛查策略及其在中国的临床适用性。
Ultrasound Obstet Gynecol. 2021 Oct;58(4):529-539. doi: 10.1002/uog.23645.
6
Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.初产妇中,早孕期子痫前期筛查阳性患者的妊娠结局:大型产科综合征队列研究。
Am J Obstet Gynecol. 2021 Feb;224(2):204.e1-204.e7. doi: 10.1016/j.ajog.2020.08.008. Epub 2020 Aug 7.
7
Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.多变量模型中,高风险队列中预测先兆子痫及其亚型:高糖基化人绒毛膜促性腺激素。
BMC Pregnancy Childbirth. 2018 Jul 3;18(1):279. doi: 10.1186/s12884-018-1908-9.
8
Ultrasound features prior to 11 weeks' gestation and first-trimester maternal factors in prediction of hypertensive disorders of pregnancy.11 孕周前的超声特征和早孕期母体因素预测妊娠高血压疾病。
Ultrasound Obstet Gynecol. 2020 May;55(5):629-636. doi: 10.1002/uog.21962.
9
Prediction of small-for-gestational-age neonates: screening by maternal biochemical markers at 30-34 weeks.预测小于胎龄儿:30-34 孕周时的母体生化标志物筛查。
Ultrasound Obstet Gynecol. 2015 Aug;46(2):208-15. doi: 10.1002/uog.14861.
10
Associations between first-trimester screening biomarkers and maternal characteristics with gestational diabetes mellitus in Chinese women.早孕期筛查生物标志物与中国孕妇妊娠期糖尿病相关的母性特征的关系。
Front Endocrinol (Lausanne). 2024 Aug 8;15:1383706. doi: 10.3389/fendo.2024.1383706. eCollection 2024.

引用本文的文献

1
[Not Available].[不可用]。
Adv Lab Med. 2025 Feb 28;6(2):144-153. doi: 10.1515/almed-2024-0110. eCollection 2025 Jun.
2
Implementation of circulating cell-free DNA screening for fetal aneuploidies.循环游离DNA筛查胎儿非整倍体的实施
Adv Lab Med. 2025 Mar 25;6(2):135-143. doi: 10.1515/almed-2025-0055. eCollection 2025 Jun.
3
Hierarchical Classification of Factors Associated With Noninvasive Prenatal Testing Failures and Its Impact on Pregnancy Outcomes.与无创产前检测失败相关因素的分层分类及其对妊娠结局的影响
Matern Fetal Med. 2024 Oct 11;6(4):215-224. doi: 10.1097/FM9.0000000000000248. eCollection 2024 Oct.
4
Study protocol for a descriptive analysis of non-invasive prenatal testing uptake and performance in singleton and twin pregnancies using Ontario birth registry data.利用安大略省出生登记数据对单胎和双胎妊娠中非侵入性产前检测的采用情况和性能进行描述性分析的研究方案。
BMJ Open. 2025 May 14;15(5):e095318. doi: 10.1136/bmjopen-2024-095318.
5
Factors, pregnancy outcomes, and management associated with non-reportable results in prenatal cell-free DNA testing.与产前游离DNA检测不可报告结果相关的因素、妊娠结局及管理
Arch Gynecol Obstet. 2025 Feb 18. doi: 10.1007/s00404-025-07977-w.
6
The association between the amount of fetal fraction in cell-free DNA testing and adverse pregnancy outcomes: A cohort study.游离DNA检测中胎儿游离DNA比例与不良妊娠结局的关联:一项队列研究。
Int J Reprod Biomed. 2024 Jan 10;22(11):919-926. doi: 10.18502/ijrm.v22i11.17824. eCollection 2024 Nov.
7
Low fetal fraction and adverse pregnancy outcomes- systematic review of the literature and metanalysis.低胎儿比例与不良妊娠结局——文献系统评价与荟萃分析。
Arch Gynecol Obstet. 2024 Sep;310(3):1343-1354. doi: 10.1007/s00404-024-07638-4. Epub 2024 Jul 15.
8
The Association between Low Fetal Fraction of Non-Invasive Prenatal Testing and Adverse Pregnancy Outcomes for Placental Compromise.无创产前检测低胎儿游离DNA比例与胎盘功能不全不良妊娠结局的关联
Diagnostics (Basel). 2024 May 15;14(10):1020. doi: 10.3390/diagnostics14101020.
9
Analysis of retest reliability for pregnant women undergoing cfDNA testing with a no-call result.对 cfDNA 检测无结果的孕妇进行复测可靠性分析。
Mol Biol Rep. 2023 Sep;50(9):7649-7657. doi: 10.1007/s11033-023-08591-2. Epub 2023 Aug 3.
10
Correlation of low fetal fraction of cell-free DNA at the early second-trimester and pregnancy complications related to placental dysfunction in twin pregnancy.孕中期早期游离DNA低胎儿分数与双胎妊娠胎盘功能障碍相关妊娠并发症的相关性
Front Med (Lausanne). 2022 Dec 1;9:1011366. doi: 10.3389/fmed.2022.1011366. eCollection 2022.